To include your compound in the COVID-19 Resource Center, submit it here.

Theravance telavancin Phase II data

THRX said in the Phase II FAST 2 trial, its telavancin

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE